Downregulation of <scp>NDR</scp>1 contributes to metastasis of prostate cancer cells via activating epithelial‐mesenchymal transition
Juntao Yue(Xijing Hospital), Chen Shao(Xiamen University)
Cited by 17
Related Papers
TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer
|Oncotarget|2015|35
TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC
|Cell Death and Disease|2022|32
Alisol B 23-Acetate Inhibits IgE/Ag-Mediated Mast Cell Activation and Allergic Reaction
|International Journal of Molecular Sciences|2018|22
Discovery of a small-molecule NDR1 agonist for prostate cancer therapy
|Frontiers in Pharmacology|2024|2